Bios Equity Partners, LP

Holdings History for Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

Symbol: LTRN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 960,026 shares
Security Ownership %: 8.6%

BIOS CAPITAL MANAGEMENT, LP ownership in Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN)

23 Feb 2026 - BIOS CAPITAL MANAGEMENT, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 960,026 shares of Lantern Pharma Inc. Common Stock, par value $0.0001 per share (LTRN). This represents 8.6% ownership of the company. In their previous filing dated 13 Jun 2025, Bios Equity Partners, LP had reported owning 1,075,952 shares, indicating a decrease of +11%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BIOS CAPITAL MANAGEMENT, LP	8.6%	-14%	$2,908,879	960,026	-115,926	-11%	$3.03	13D/A	20 Feb 2026	23 Feb 2026, 16:37
CAVU MANAGEMENT, LP	10%		$4,153,175	1,075,952			$3.86	13D/A	12 Jun 2025	13 Jun 2025, 19:43